Benzinga's Top #PreMarket Losers
Targacept (NASDAQ: TRGT) shares fell 31.93% to $4.05 in the pre-market trading after the company announced negative top-line results from Phase 2b clinical trial of TC-5619 in Schizophrenia.
Rockwell Medical (NASDAQ: RMTI) dipped 12.03% to $11.85. Brean Capital initiated coverage on the stock with a Sell rating.
Expedia (NASDAQ: EXPE) dipped 7.47% to $60.96 in the pre-market session. Expedia's trailing-twelve-month profit margin is 3.15%.
Fiserv (NASDAQ: FISV) shares dropped 3.21% to $54.87 in pre-market trading. Fiserv's PEG ratio is 2.67.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.